Oncternal Therapeutics, Inc. (ONCT)
Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534. The company was founded by David F. Hale and James B. Breitmeyer in September 1997 and is headquartered in San Diego, CA.
Address
12230 EL CAMINO REAL
SAN DIEGO, CA 92130
Founded
1997
Number of Employees
27
Website
http://www.oncternal.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)